Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C
Status:
Recruiting
Trial end date:
2022-12-20
Target enrollment:
Participant gender:
Summary
The safety, tolerability and antiviral activity of Antaitavir Hasophate in Combination With
Yiqibuvir in treatment-naive and treatment-experienced patients with chronic hepatitis C
virus (HCV) infection